“…Isolates of pandrug-resistant A. baumannii (PDRAB), which are resistant to all antibiotics routinely tested (i.e., ampicillin-sulbactam, ceftazidime, piperacillin-tazobactam, cefepime, aztreonam, ciprofloxacin, trovafloxacin, moxifloxacin, garenoxacin, amikacin, imipenem, and meropenem), were first recovered in May 1998 at the National Taiwan University Hospital (NTUH) (14,17). Since then, clusters of PDRAB infections and nosocomial outbreaks have persisted, although the incidence of nosocomial infections caused by PDRAB has declined in the past 2 years (12,13,15).…”